课题基金 / 基金详情

Molecular mechanism of cancer cell pluripotency responding to stress

Molecular mechanism of cancer cell pluripotency responding to stress
癌细胞多能性响应应激的分子机制
批准号:
24659149
负责人:
KANEDA Yasufumi
金额:
$2.5万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Challenging Exploratory Research
财政年份:
2012
资助国家:
日本
项目状态:
已结题
起止时间:
2012-04-01 至 2014-03-31

项目摘要

项目成果

KANEDA Yasufumi的其他基金

相似基金

相关文献

中文摘要
翻译
尽管多西他赛难治性前列腺癌患者的患病率越来越高,但对其肿瘤生物学知之甚少。在这项研究中,我们证明了与亲代前列腺癌细胞相比,耐紫杉醇的残留前列腺癌细胞的致瘤潜力增加。CXCR 4、ERK 1/2和c-Myc信号环激活控制了增强的致瘤潜力。此外,组成型CXCR 4,ERK 1/2和c-Myc信号传导激活在来自紫杉醇耐药前列腺癌患者的临床癌组织样品中得到证实。这些信号通路可能成为化疗后抑制侵袭性残留肿瘤细胞的治疗靶点。
英文摘要
Despite an increasing prevalence of patients with docetaxel refractory prostate cancer, little is known about its tumour biology. In this study, we demonstrated that the tumourigenic potential was increased in the docetaxel-resistant residual prostate cancer cells compared with the parental prostate cancer cells. An enhanced tumourigenic potential was controlled by the CXCR4, ERK1/2 and c-Myc signalling loop activation. Furthermore, the constitutive CXCR4, ERK1/2 and c-Myc signalling activation was demonstrated in clinical cancerous tissue samples from human patients with docetaxel-resistant prostate cancer. These signalling pathways may become treatment targets for inhibiting aggressive residual tumour cells after chemotherapy.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
大阪大学大学院学系研究科遺伝子治療学
大阪大学基因治疗研究科
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Future direction of gene therapy
基因治疗的未来方向
DOI: --
发表时间: 2012
期刊:
影响因子: --
作者: [Hatano K, Yamaguchi S, Nimura K, Murakami K, Nagahara A, Fujita K, Uemura M, Nakai Y, Tsuchiya M, Nakayama M, Nonomura N, *Kaneda Y., 金田安史, 金田安史]
通讯作者: 金田安史
Future directions of gene therapy
基因治疗的未来方向
DOI: --
发表时间: 2012
期刊:
影响因子: --
作者: [Hatano K, Yamaguchi S, Nimura K, Murakami K, Nagahara A, Fujita K, Uemura M, Nakai Y, Tsuchiya M, Nakayama M, Nonomura N, *Kaneda Y., 金田安史, 金田安史, 金田安史]
通讯作者: 金田安史
6
    Development of multi-lateral cancer gene therapy by enhancing anti-tumor activity of inactivated Sendai virus particle
    • 批准号:
      22300339
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.15万
    • 财政年份:
      2010
    • 负责人:
      KANEDA Yasufumi
    • 依托单位:
    Transcriptional regulation of osteogenesis using siRNA and its application to bone formation
    • 批准号:
      17300153
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $7.55万
    • 财政年份:
      2005
    • 负责人:
      KANEDA Yasufumi
    • 依托单位:
    Development of anti-cancer strategy to increase sensitivity of cancer cells to chemotherapy using siRNA combined with HVJ-E vector
    • 批准号:
      15300163
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.51万
    • 财政年份:
      2003
    • 负责人:
      KANEDA Yasufumi
    • 依托单位:
    Development of slow release reagent of NFkB decoy oligodeoxynucleotides for the treatment of rheumatic arthritis
    • 批准号:
      13558109
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.13万
    • 财政年份:
      2001
    • 负责人:
      KANEDA Yasufumi
    • 依托单位:
    海外基金